APA (7th ed.) Citation

Baluom, M., Grossbard, E. B., Mant, T., & Lau, D. T. W. (2013). Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies. British journal of clinical pharmacology, 76(1), 78-88. https://doi.org/10.1111/bcp.12048

Chicago Style (17th ed.) Citation

Baluom, Muhammad, Elliott B. Grossbard, Tim Mant, and David T. W. Lau. "Pharmacokinetics of Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, in Healthy Human Subjects Following Single and Multiple Oral Dosing in Three Phase I Studies." British Journal of Clinical Pharmacology 76, no. 1 (2013): 78-88. https://doi.org/10.1111/bcp.12048.

MLA (9th ed.) Citation

Baluom, Muhammad, et al. "Pharmacokinetics of Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, in Healthy Human Subjects Following Single and Multiple Oral Dosing in Three Phase I Studies." British Journal of Clinical Pharmacology, vol. 76, no. 1, 2013, pp. 78-88, https://doi.org/10.1111/bcp.12048.